IM administration has been tested as an immune priming technique for subsequent IV injections of oncolytic maraba virus in a metastatic lung model of murine melanoma, where activation of CD8+ T-cells facilitated significantly increased survival rates [19]. Here, CD8A is linked to melanoma.